{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:16:33Z","timestamp":1790388993482,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Brazilian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.bjid.2025.104515","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T01:02:26Z","timestamp":1740099746000},"page":"104515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Experience in Ceftazidime-Avibactam for treatment of MDR BGN infection in Oncologic Children"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-9440-5829","authenticated-orcid":false,"given":"Wilson Toyohiro","family":"Hoshino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6725-314X","authenticated-orcid":false,"given":"Adriana Maria Paix\u00e3o De Sousa","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Carlos","family":"Pignatari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cristina","family":"Gales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7037-3425","authenticated-orcid":false,"given":"Fabianne","family":"Carlesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjid.2025.104515_bib0001","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/mdr.2019.0393","article-title":"Prevalence, epidemiology, etiology, and sensitivity of invasive bacterial infections in pediatric patients undergoing oncological treatment: A multicenter nationwide study","volume":"27","author":"Zajac-Spychala","year":"2021","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.bjid.2025.104515_bib0002","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1200\/JCO.2001.19.14.3415","article-title":"Prospective, multicenter evaluation of risk factors asalsociated with invasive bacterial infection in children with cancer, neutropenia, and fever","volume":"19","author":"Santolaya","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bjid.2025.104515_bib0003","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.paed.2019.12.002","article-title":"Febrile neutropenia in paediatric oncology","volume":"30","author":"Davis","year":"2020","journal-title":"Paediatr Child Health (Oxford)"},{"key":"10.1016\/j.bjid.2025.104515_bib0004","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1200\/JCO.22.02224","article-title":"Guideline for the management of fever and neutropenia in pediatric patients with cancer and hematopoietic cell transplantation recipients: 2023 update","volume":"41","author":"Lehrnbecher","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bjid.2025.104515_bib0005","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1056\/NEJM197105132841904","article-title":"Empiric therapy with Carbenicillin and Gentamicin for Febrile patients with cancer and granulocytopenia","volume":"284","author":"Schimpff","year":"1971","journal-title":"New Engl J Med"},{"key":"10.1016\/j.bjid.2025.104515_bib0006","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jpeds.2018.06.056","article-title":"National Trends in hospitalization for fever and neutropenia in children with cancer, 2007-2014","volume":"202","author":"Lekshminarayanan","year":"2018","journal-title":"J Pediatr"},{"key":"10.1016\/j.bjid.2025.104515_bib0007","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3390\/antibiotics10030266","article-title":"Antibiotic resistant bloodstream infections in pediatric patients receiving chemotherapy or hematopoietic stem cell transplant: factors associated with development of resistance, intensive care admission and mortality","volume":"10","author":"Castagnola","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.bjid.2025.104515_bib0008","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.2147\/IDR.S238567","article-title":"Optimising antimicrobial selection and duration in the treatment of Febrile Neutropenia in children","volume":"14","author":"Morgan","year":"2021","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.bjid.2025.104515_bib0009","doi-asserted-by":"crossref","first-page":"e445","DOI":"10.1097\/MPH.0000000000001814","article-title":"Pediatric Febrile Neutropenia: change in etiology of bacteremia, empiric choice of therapy and clinical outcomes","volume":"42","author":"Alali","year":"2020","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.bjid.2025.104515_bib0010","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1093\/cid\/ciu052","article-title":"The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies","volume":"58","author":"Satlin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2025.104515_bib0011","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cmi.2021.05.002","article-title":"Clinical management of severe infections caused by carbapenem-resistant gram-negative bacteria: a worldwide cross-sectional survey addressing the use of antibiotic combinations","volume":"28","author":"Carrara","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bjid.2025.104515_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2020.12.009","article-title":"Systematic review on estimated rates of nephrotoxicity and neurotoxicity in patients treated with polymyxins","author":"Wagenlehner","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bjid.2025.104515_bib0013","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/cid\/ciu069","article-title":"Treatment of multidrug-resistant gram-negative infections in children","volume":"58","author":"Hsu","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2025.104515_bib0014","doi-asserted-by":"crossref","first-page":"dlac073","DOI":"10.1093\/jacamr\/dlac073","article-title":"Use of polymyxins for carbapenem-resistant infections in children and adolescents","volume":"4","author":"Barco-Cabrera","year":"2022","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.bjid.2025.104515_bib0015","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant gram-negative bacilli (endorsed by European society of intensive care medicine)","volume":"28","author":"Paul","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bjid.2025.104515_bib0016","article-title":"Infectious Diseases Society of America Antimicrobial-resistant treatment guidance: gram-negative bacterial infections","author":"Tamma","year":"2023","journal-title":"Infect Dis Soc Am"},{"key":"10.1016\/j.bjid.2025.104515_bib0017","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.2147\/DDDT.S467967","article-title":"Ceftazidime-Avibactam as a salvage treatment for severely infected immunosuppressed children","volume":"18","author":"Zhu","year":"2024","journal-title":"Drug Des Devel Ther."},{"key":"10.1016\/j.bjid.2025.104515_bib0018","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1097\/INF.0000000000003716","article-title":"Ceftolozane\/Tazobactam and Ceftazidime\/Avibactam: an Italian multi-center retrospective analysis of safety and efficacy in children with hematologic malignancies and multi-drug resistant gram-negative bacteria infections","volume":"41","author":"Perruccio","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.bjid.2025.104515_bib0019","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/INF.0000000000002395","article-title":"Safety and efficacy of Ceftazidime-Avibactam in the treatment of children \u22653 months to <18 years with complicated urinary tract infection: results from a phase 2 randomized, controlled trial","volume":"38","author":"Bradley","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.bjid.2025.104515_bib0020","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/INF.0000000000002392","article-title":"Safety and efficacy of Ceftazidime-Avibactam Plus metronidazole in the treatment of children \u22653 months to <18 years with complicated intra-abdominal infection: results from a phase 2, randomized, controlled trial","volume":"38","author":"Bradley","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.bjid.2025.104515_bib0021","series-title":"Core Elements of Hospital Antibiotic Stewardship Programs","year":"2019"},{"key":"10.1016\/j.bjid.2025.104515_bib0022","unstructured":"Comite Brasileiro de Teste de Sensibilidade aos Antimicrobianos (BrCAST). Documentos\/documentos atuais\/tabelas de pontos de corte, instru\u00e7\u00f5es e outros documentos. Rio de Janeiro, 2023. available at: https:\/\/brcast.org.br\/documentos-3\/."},{"key":"10.1016\/j.bjid.2025.104515_bib0023","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bjid.2025.104515_bib0024","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/jac\/dkr563","article-title":"Rapid detection of carbapenemase genes by multiplex real-time PCR","volume":"67","author":"Monteiro","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bjid.2025.104515_bib0025","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/jac\/dkg416","article-title":"Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase","volume":"52","author":"Gales","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bjid.2025.104515_bib0026","unstructured":"No time to wait: securing the future from drug-resistant infections report to the Secretary-General of the United Nations April 2019, World Health Organization."},{"key":"10.1016\/j.bjid.2025.104515_bib0027","doi-asserted-by":"crossref","first-page":"7223","DOI":"10.1038\/s41598-022-11295-5","article-title":"Risk factors for antibiotic-resistant bacteria colonisation in children with chronic complex conditions","volume":"12","author":"Agud","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.bjid.2025.104515_bib0028","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.3324\/haematol.2009.020867","article-title":"Infection Study Group of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP). Multidrug resistant Pseudomonas aeruginosa infection in children undergoing chemotherapy and hematopoietic stem cell transplantation","volume":"95","author":"Caselli","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.bjid.2025.104515_bib0029","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jped.2014.11.009","article-title":"Infection with multidrug-resistant gram-negative bacteria in a pediatric oncology intensive care unit: risk factors and outcomes","volume":"91","author":"de Oliveira Costa","year":"2015","journal-title":"J Pediatr (Rio J)"},{"key":"10.1016\/j.bjid.2025.104515_bib0030","article-title":"Efficacy and safety of Ceftazidime-Avibactam for the treatment of carbapenem-resistant enterobacterales bloodstream infection: a systematic review and meta-analysis","volume":"10","author":"Chen","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.bjid.2025.104515_bib0031","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.emc.2013.07.002","article-title":"Fever in immunocompromised hosts","volume":"31","author":"Patel","year":"2013","journal-title":"Emerg Med Clin North Am"},{"key":"10.1016\/j.bjid.2025.104515_bib0032","unstructured":"Nota t\u00e9cnica n\u00b0 74\/2022-CGLAB\/DAEVS\/SVS\/MS. Acessado em 30\/08\/2023 11h https:\/\/brcast.org.br\/wp-content\/uploads\/2022\/09\/SEI_MS-0028220258-Nota-Tecnica-NDM-e-coproducao-carbapenemase.pdf."},{"key":"10.1016\/j.bjid.2025.104515_bib0033","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1093\/cid\/ciy378","volume":"67","author":"Kadri","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2025.104515_bib0034","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.biotechadv.2018.11.013","article-title":"Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies","volume":"37","author":"Pang","year":"2019","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.bjid.2025.104515_bib0035","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3390\/antibiotics11080985","article-title":"Pseudomonas fluorescens complex and its intrinsic, adaptive, and acquired antimicrobial resistance mechanisms in pristine and Human-impacted sites","volume":"11","author":"Silverio","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.bjid.2025.104515_bib0036","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1590\/S0037-86822010000400007","article-title":"Molecular characterization of carbapenem-resistant and metallo-\u03b2-lactamase-producing Pseudomonas aeruginosa isolated from blood cultures from children and teenagers with cancer","volume":"43","author":"Fernandes","year":"2010","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.bjid.2025.104515_bib0037","unstructured":"OMS. Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19. 2020. Dispon\u00edvel em: https:\/\/saude.shortcm.li\/LT9LzV."},{"key":"10.1016\/j.bjid.2025.104515_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.micinf.2021.104806","article-title":"Bacterial and fungal co-infections among COVID-19 patients in intensive care unit","volume":"23","author":"Yang","year":"2021","journal-title":"Microbes Infect"},{"key":"10.1016\/j.bjid.2025.104515_bib0039","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1038\/s41598-023-28438-x","article-title":"Stenotrophomonas maltophilia pneumonia in critical COVID-19 patients","volume":"13","author":"Raad","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.bjid.2025.104515_bib0040","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3389\/fmicb.2015.00658","article-title":"Antibiotic resistance in the opportunistic pathogen Stenotrophomonas maltophilia","volume":"6","author":"S\u00e1nchez","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bjid.2025.104515_bib0041","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1093\/cid\/ciaa586","article-title":"Efficacy of Ceftazidime-avibactam plus Aztreonam in patients with bloodstream infections caused by metallo-\u03b2-lactamase-producing enterobacterales","volume":"72","author":"Falcone","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2025.104515_bib0042","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.2147\/IDR.S306222","article-title":"Successful treatment of ventriculitis caused by MDR\/XDR gram-negative Bacillus using ceftazidime\/Avibactam: case series and literature review","volume":"14","author":"Zhou","year":"2021","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.bjid.2025.104515_bib0043","doi-asserted-by":"crossref","first-page":"ofaa349","DOI":"10.1093\/ofid\/ofaa349","article-title":"Using therapeutic drug monitoring to treat KPC-producing Klebsiella pneumoniae Central nervous system infection with Ceftazidime\/Avibactam","volume":"7","author":"Yasmin","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.bjid.2025.104515_bib0044","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.2147\/IDR.S403527","article-title":"Ceftazidime-avibactam treatment for severe post-neurosurgical meningitis and abscess caused by extended-spectrum \u03b2-lactamase Escherichia coli in a pediatric patient: A case report","volume":"16","author":"Ren","year":"2023","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.bjid.2025.104515_bib0045","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s15010-022-01834-7","article-title":"Successful ceftazidime\u2013avibactam therapy in a patient with multidrug-resistant Pseudomonas aeruginosa infective endocarditis","volume":"50","author":"Lima","year":"2022","journal-title":"Infection"},{"key":"10.1016\/j.bjid.2025.104515_bib0046","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s40121-021-00507-6","article-title":"Ceftazidime-avibactam for the treatment of serious gram-negative infections with limited treatment options: A systematic literature review","volume":"10","author":"Soriano","year":"2021","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.bjid.2025.104515_bib0047","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1093\/cid\/cis210","article-title":"Pharmacokinetic and pharmacodynamic issues for antimicrobial therapy in patients with cancer","volume":"54","author":"Theuretzbacher","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2025.104515_bib0048","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/cpt.2460","article-title":"Population pharmacokinetic modeling and probability of pharmacodynamic target attainment for ceftazidime-Avibactam in pediatric patients aged 3 months and older","volume":"111","author":"Franzese","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bjid.2025.104515_bib0049","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3390\/antibiotics11050628","article-title":"Resistance to Ceftazidime\/Avibactam, Meropenem\/Vaborbactam and Imipenem\/Relebactam in gram-negative MDR Bacilli: molecular mechanisms and susceptibility testing","volume":"11","author":"Gaibani","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.bjid.2025.104515_bib0050","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.00585-21","article-title":"Time-kill evaluation of antibiotic combinations containing Ceftazidime-Avibactam against extensively drug-resistant Pseudomonas aeruginosa and their potential role against ceftazidime-Avibactam-resistant isolates","volume":"9","author":"Montero","year":"2021","journal-title":"Microbiol Spectr"}],"container-title":["The Brazilian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867025000182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867025000182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T08:07:53Z","timestamp":1744445273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1413867025000182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1413867025000182"],"URL":"https:\/\/doi.org\/10.1016\/j.bjid.2025.104515","relation":{},"ISSN":["1413-8670"],"issn-type":[{"value":"1413-8670","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experience in Ceftazidime-Avibactam for treatment of MDR BGN infection in Oncologic Children","name":"articletitle","label":"Article Title"},{"value":"The Brazilian Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjid.2025.104515","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedade Brasileira de Infectologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"104515"}}